Morphine Sulfate 25 mg/mL Injectable, 40 mL vial, compounded by The Compounding Shop, St. Petersburg, FL
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Prescription and over-the-counter medications
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Petnet Solution
cGMP Deviation
THE COMPOUNDING SHOP
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.